Literature DB >> 16687917

Oxygen sensing: recent insights from idiopathic erythrocytosis.

Frank S Lee1, Melanie J Percy, Mary Frances McMullin.   

Abstract

Idiopathic erythrocytosis (IE) is a rare condition in which there is an increase in red cell mass and hematocrit. As it is typically driven by elevated or inappropriately normal erythropoietin (Epo) levels, it has the potential to reveal the identities of proteins involved in the oxygen sensing pathway that regulates the transcription factor, Hypoxia Inducible Factor (HIF), and hence Epo production in humans. One example of this is provided by Chuvash polycythemia, a form of erythrocytosis due to a mutation in the von Hippel Lindau tumor suppressor protein (VHL), a component of an E3 ubiquitin ligase complex that targets hydroxylated HIF for degradation. A recent report of familial erythrocytosis now implicates a different protein, Prolyl Hydroxylase Domain protein 2 (PHD2), which is an enzyme that hydroxylates HIF.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16687917      PMCID: PMC2422869          DOI: 10.4161/cc.5.9.2723

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  55 in total

1.  Erythrocytosis and the Chuvash von Hippel-Lindau mutation.

Authors:  Melanie J Percy; Michael E J Beard; Chris Carter; Swee Lay Thein
Journal:  Br J Haematol       Date:  2003-10       Impact factor: 6.998

2.  Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia.

Authors:  Sonny O Ang; Hua Chen; Kiichi Hirota; Victor R Gordeuk; Jaroslav Jelinek; Yongli Guan; Enli Liu; Adelina I Sergueeva; Galina Y Miasnikova; David Mole; Patrick H Maxwell; David W Stockton; Gregg L Semenza; Josef T Prchal
Journal:  Nat Genet       Date:  2002-11-04       Impact factor: 38.330

3.  The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1 and HIF-1alpha in renal cell carcinoma.

Authors:  S C Clifford; D Astuti; L Hooper; P H Maxwell; P J Ratcliffe; E R Maher
Journal:  Oncogene       Date:  2001-08-16       Impact factor: 9.867

4.  Chuvash-type congenital polycythemia in 4 families of Asian and Western European ancestry.

Authors:  Melanie J Percy; Mary Frances McMullin; Simon N Jowitt; Michael Potter; Marilyn Treacy; William H Watson; Terence R J Lappin
Journal:  Blood       Date:  2003-04-17       Impact factor: 22.113

5.  Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation.

Authors:  N Masson; C Willam; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  EMBO J       Date:  2001-09-17       Impact factor: 11.598

6.  HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation.

Authors:  F Yu; S B White; Q Zhao; F S Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

7.  Mutations of von Hippel-Lindau tumor-suppressor gene and congenital polycythemia.

Authors:  Yves Pastore; Katerina Jedlickova; Yongli Guan; Enli Liu; James Fahner; Henrik Hasle; Jaroslav F Prchal; Josef T Prchal
Journal:  Am J Hum Genet       Date:  2003-07-03       Impact factor: 11.025

8.  Sequence variation in hypoxia-inducible factor 1alpha (HIF1A): association with maximal oxygen consumption.

Authors:  Steven J Prior; James M Hagberg; Dana A Phares; Michael D Brown; Liane Fairfull; Robert E Ferrell; Stephen M Roth
Journal:  Physiol Genomics       Date:  2003-09-29       Impact factor: 3.107

9.  Human hormone-refractory prostate cancers can harbor mutations in the O(2)-dependent degradation domain of hypoxia inducible factor-1alpha (HIF-1alpha).

Authors:  Aristotelis G Anastasiadis; Mohamed A Ghafar; Laurent Salomon; Francis Vacherot; Patricia Benedit; Min-Wei Chen; Ahmad Shabsigh; Martin Burchardt; Dominique K Chopin; Ridwan Shabsigh; Ralph Buttyan
Journal:  J Cancer Res Clin Oncol       Date:  2002-05-16       Impact factor: 4.553

10.  Mutations in the VHL gene in sporadic apparently congenital polycythemia.

Authors:  Yves D Pastore; Jaroslav Jelinek; Sonny Ang; Yongli Guan; Enli Liu; Katerina Jedlickova; Lakshmanan Krishnamurti; Josef T Prchal
Journal:  Blood       Date:  2002-10-10       Impact factor: 22.113

View more
  6 in total

1.  A novel erythrocytosis-associated PHD2 mutation suggests the location of a HIF binding groove.

Authors:  Melanie J Percy; Paul W Furlow; Philip A Beer; Terence R J Lappin; Mary Frances McMullin; Frank S Lee
Journal:  Blood       Date:  2007-06-19       Impact factor: 22.113

2.  Gene panel sequencing improves the diagnostic work-up of patients with idiopathic erythrocytosis and identifies new mutations.

Authors:  Carme Camps; Nayia Petousi; Celeste Bento; Holger Cario; Richard R Copley; Mary Frances McMullin; Richard van Wijk; Peter J Ratcliffe; Peter A Robbins; Jenny C Taylor
Journal:  Haematologica       Date:  2016-09-20       Impact factor: 9.941

Review 3.  Genetic causes of erythrocytosis and the oxygen-sensing pathway.

Authors:  Frank S Lee
Journal:  Blood Rev       Date:  2008-06-05       Impact factor: 8.250

4.  Erythrocytosis-associated HIF-2alpha mutations demonstrate a critical role for residues C-terminal to the hydroxylacceptor proline.

Authors:  Paul W Furlow; Melanie J Percy; Scott Sutherland; Charlene Bierl; Mary Frances McMullin; Stephen R Master; Terence R J Lappin; Frank S Lee
Journal:  J Biol Chem       Date:  2009-02-10       Impact factor: 5.157

5.  A gain-of-function mutation in the HIF2A gene in familial erythrocytosis.

Authors:  Melanie J Percy; Paul W Furlow; Guy S Lucas; Xiping Li; Terence R J Lappin; Mary Frances McMullin; Frank S Lee
Journal:  N Engl J Med       Date:  2008-01-10       Impact factor: 91.245

6.  Computational analysis of prolyl hydroxylase domain-containing protein 2 (PHD2) mutations promoting polycythemia insurgence in humans.

Authors:  Giovanni Minervini; Federica Quaglia; Silvio C E Tosatto
Journal:  Sci Rep       Date:  2016-01-12       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.